Abstract:Cellular senescence is implicated in ageing and associated with a broad spectrum of age-related diseases. Importantly, a cell can initiate the senescence program irrespective of the organism's age. Various stress signals, including those defined as ageing hallmarks and alterations leading to cancer development, oncogene activation, or loss of cancer-suppressive functions, can trigger cellular senescence. The primary outcome of these alterations is the activation of nuclear factor (NF)-κB, thereby inducing the senescence-associated secretory phenotype (SASP). Proinflammatory cytokines and chemokines, components of this phenotype, contribute to chronic systemic sterile inflammation, commonly referred to as inflamm-ageing. This inflammation is linked to age-related diseases (ARDs), frailty, and increased mortality in older individuals. Additionally, senescent cells (SCs) accumulate in multiple tissues with age and are believed to underlie the organism functional decline, as demonstrated by models. An escalating effort has been dedicated to identify senotherapeutics that selectively target SCs by inducing apoptosis; these drugs are termed senolytics. Concurrently, small molecules that suppress senescent phenotypes without causing cell death are known as senomorphics. Both natural and synthetic senotherapeutics, along with immunotherapies employing immune cell-mediated clearance of SCs, currently represent the most promising strategies to combat ageing and ARDs. Indeed, it is fascinating to observe that information regarding the immune reaction to SCs indicates that regulation by specific lymphocyte subsets, elevated in the oldest centenarians, plays a role in attaining extreme longevity. Regardless, the application of methods already utilized in cancer treatment, such as CAR cells and monoclonal antibodies, broadens the spectrum of potential approaches to be utilized.

Rejuvenating aged stem cells: therapeutic strategies to extend health and lifespan

Senescence in Mesenchymal Stem Cells: Functional Alterations, Molecular Mechanisms, and Rejuvenation Strategies.

Restoring aged stem cell functionality: Current progress and future directions

Transplanting rejuvenated blood stem cells extends lifespan of aged immunocompromised mice

Focus on senescence: Clinical significance and practical applications

Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases

Targeting Senescent Cells for a Healthier Longevity: the Roadmap for an Era of Global Aging

Stem cells and anti-aging genes: double-edged sword—do the same job of life extension

Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies

Metabolic Regulation: A Potential Strategy for Rescuing Stem Cell Senescence

Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review

Senescent Mesenchymal Stem/stromal Cells and Restoring Their Cellular Functions

Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease

Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies

Epigenetic Reprogramming as a Key to Reverse Ageing and Increase Longevity

Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies

Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges.

Mitochondria pleiotropism in stem cell senescence: Mechanisms and therapeutic approaches

Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells

A Comprehensive Exploration of Gene, Cellular, and Pharmacological Anti-Aging Strategies

Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities